It is kind of difficult to answer that question because we aren't actually sure what the federal government is going to do in this particular area. The question may, unfortunately, be a little premature, but what I can say is that we are watching this very closely. Regardless of which government makes up the federal government in the next term, I am hopeful and optimistic that they will continue to work on pharmacare, and we as a government should and must continue to make sure that our voice is heard during those discussions, but frankly I think it's a little early to speculate on what it might look like. It might be a hypothetical response, and I'm not prepared to do that at this point.